http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0365149-A3

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C45-71
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D233-84
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C323-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D309-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C323-60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D307-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C323-67
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D233-90
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C255-33
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C47-55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C45-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C47-548
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-19
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C45-62
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C45-673
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C45-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C47-542
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C45-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D307-54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C47-546
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D257-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C47-575
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D303-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C45-298
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C323-66
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D303-40
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-415
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C45-71
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C45-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C47-548
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C45-67
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D303-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-215
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D309-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C45-62
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D303-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C323-67
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C323-66
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C255-33
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C45-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C323-60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D333-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D257-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-19
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C323-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C323-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-165
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C47-575
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C323-41
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C47-55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C47-546
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C45-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C47-542
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C45-29
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C323-25
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D233-90
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D233-84
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D307-54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-275
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D307-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00
filingDate 1989-09-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 1990-07-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-0365149-A3
titleOfInvention Leukotriene antagonist prodrugs
abstract A compound represented by the following structural nformula (I): n nwherein n (a) R₁ is C₈ to C₁₃ alkyl, C₇ to C₁₂ alkoxy, C₇ to C₁₂ nalkylthio, C₁₀ to C₁₂ 1-alkynyl, 10-undecynyloxy, 11-­ndodecynyl, phenyl-C₄ to C₁₀ alkyl, phenyl-C₃ to C₉ alkoxy, nphenylthio-C₃ to C₉ alkyl with the phenyl optionally mono nsubstituted with bromo, chloro, trifluoromethyl, nalkoxy, methylthio or trifluoromethylthio, thienyl-C₄ to C₁₀ nalkyl furyl-C₄ to C₁₀ alkyl,trifluoromethyl-C₇ to C₁₂ alkyl or ncycloheyl-C₄ to C₁₀ alkyl; and n    R₂ is hydrogen, bromo, chloro, methyl, trifluoromethyl, nhydroxy, alkoxy or nitro; (b) or R₁ is hydrogen and R₂ is C₈ to C₁₃ alkyl, C₇ to C₁₂ nalkoxy, C₇ to C₁₂ alkylthio, C₁₀ to C₁₂ 1-alkynyl, 10-­nundecynyloxy, 11-dodecynyl, phenyl-C₄ to C₁₀ alkyl, phenyl-C₃ nto C₉ alkoxy, phenylthio-C₃ to C₉ alkyl with the phenyl noptionally mono substituted with bromo, chloro, trifluoro­nmethyl, alkoxy, methylthio or trifluoromethylthio, nfuryl-C₄ to C₁₀ alkyl, trifluoromethyl-C₇ to C₁₂ alkyl or ncyclohexyl-C₄ to C₁₀ alkyl; n    q is 0, 1, or 2; n    Y is COR₃, CH(R₄)(CH₂) m COR₃ or CH(R₄)(CH₂) m -­ntetrazol-5-yl the tetrazol-5-yl being nunsubstituted or substituted with A; n n    R₁₆ and R₁₇ are independently hydrogen or C₁₋₄ alkyl; n    j is 0 to 6; n n n    R₁₈ is hydrogen, alkyl, COR₃, SO₃H, SO₂NH₂, COCH₂OH or nCHOHCH₂OH; n    R₃ is amino, (CH₂) n CO₂CH₂CONR₁₆R₁₇, or OR₁₄; n    R₁₄ is hydrogen, alkyl, cycloalkyl, aryl, arylalkyl, nalkylaryl, alkylarylalkyl, alkyl substituted amino or alkylamino, - nOCH₂CONR₇R₈, indanyl, pivaloyloxymethyl, acetoxymethyl, npropionyloxymethyl, glycyloxymethyl, phenylglycyloxymethyl, or nthienylglycyloxymethyl; n    R₄ is hydrogen, methyl, alkoxy, fluoro or hydroxy; n    m is 0, or 1; n    R is (CH₂) n nCOR₆, CH(CO₂H)CH₂COR₆, n(CH₂) n CO₂CH₂CONR₁₆,R₁₇, or nan imidazole of the formula n n    n is 0 to 6; n    R₅ is hydrogen, amino, or NHCOCH₂CH₂CH(NH₂)CO₂H; n    R₆ is amino, NH(CH₂) n CO₂H, SO₃H, SO₂NH₂, CN, tetrazol-5-yl nunsubstituted or substituted with A as defined above, or OR₁₅; n    R₇ is hydrogen, alkyl or alkenyl; n    R₈ is hydrogen, alkyl, carboxyl or carboxamido, or, nwhen R₇ and R₉ are hydrogen or alkyl, (CH₂) m COOR₁₅; n    R₉ is hydrogen, alkyl or (CH₂) m COOR₁₅; n    R₁₅ is hydrogen, alkyl, cycloalkyl, aryl, narylalkyl, alkylaryl, alkylarylalkyl, allayl substituted amino nor alkylamino, -OCH₂CONR₇R₈, indanyl, pivaloyloxymethyl, nacetoxymethyl, propionyloxymethyl, glycyloxymethyl, nphenylglycyloxymethyl, or thienylglycyloxymethyl; n    provided that 1) when n is 0, R₅ is hydrogen, 2) R₇, R₈ nand R₉ are not all hydrogen, 3) any of R₁and R₂ above are not nalkylthio or phenylthioalkyl when q is 1 or 2, 4) R₃ and R₆ are nnot both hydroxy, 5) OR₁₄ and OR₁₅ are not simultaneously nhydroxy; 6) if R₄ is hydroxy and m is 0, R₁₄ is hydrogen; or n    a pharmaceutically acceptable salt thereof.
priorityDate 1988-09-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0296732-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0202759-A2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226497211
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID69027
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID87069182
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID76015
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226498651
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226405611

Total number of triples: 82.